Large-scale testing (Phase 3)Ended earlyNCT00066807What this trial is testingPremenopausal Endocrine Responsive Chemotherapy TrialWho this might be right forBreast Cancer ETOP IBCSG Partners Foundation 29
Testing effectiveness (Phase 2)Ended earlyNCT03933813What this trial is testingEvaluation and Treatment of Iron Deficiency in Ovarian Cancer PatientsWho this might be right forEpithelial Ovarian CancerAnemiaIron Deficiency Anemia University of Wisconsin, Madison 9
Not applicableStudy completedNCT05489354What this trial is testingMHealth Usage Among Nigeria Women Diagnosed With Breast Cancer Receiving ChemotherapyWho this might be right forBreast Cancer Chinese University of Hong Kong 126
Testing effectiveness (Phase 2)Ended earlyNCT01251354What this trial is testingStudy of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapyWho this might be right forEndometrial Cancer Ipsen 6
Large-scale testing (Phase 3)Looking for participantsNCT07097142What this trial is testingTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER StudyWho this might be right forMuscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8 NRG Oncology 486
Testing effectiveness (Phase 2)Ended earlyNCT02834975What this trial is testingPembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).Who this might be right forFallopian Tube CancerPeritoneum CancerEpithelial Ovarian Cancer University of Miami 26
Testing effectiveness (Phase 2)WithdrawnNCT02521077What this trial is testingIntravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast CancerWho this might be right forFatigue Midwestern Regional Medical Center
Not applicableActive Not RecruitingNCT06856616What this trial is testingPredicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant ChemotherapyWho this might be right forBreast Neoplasms The Third Affiliated Hospital of Harbin Medical University 6,000
Large-scale testing (Phase 3)Study completedNCT00211133What this trial is testingEvaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving ChemotherapyWho this might be right forAnemiaBreast NeoplasmsQuality of Life Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 939
Post-approval studies (Phase 4)Study completedNCT02502864What this trial is testingMulticenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and CyclophosphamideWho this might be right forBreast CancerBreast Cancer Female H. Lee Moffitt Cancer Center and Research Institute 9
Not applicableStudy completedNCT01080521What this trial is testingChanges in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyWho this might be right forCognitive Side Effects of Cancer TherapyMalignant Ovarian Epithelial TumorOvarian Brenner Tumor+51 more Gynecologic Oncology Group 247
Testing effectiveness (Phase 2)Looking for participantsNCT06251947What this trial is testingEfbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy RegimenWho this might be right forOvarian CancerCervical Cancer Shandong University 83
Not applicableStudy completedNCT00534274What this trial is testingPositron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving ChemotherapyWho this might be right forBreast Cancer UNICANCER 97
Testing effectiveness (Phase 2)UnknownNCT00687648What this trial is testingCyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast CancerWho this might be right forBreast Cancer National Cancer Centre, Singapore 70
Large-scale testing (Phase 3)Study completedNCT00054418What this trial is testingRisedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast CancerWho this might be right forBreast CancerOsteoporosis Alliance for Clinical Trials in Oncology 216
Early research (Phase 1)Study completedNCT02527746What this trial is testingStudy of F-627 in Women With Breast Cancer Receiving Myelotoxic ChemotherapyWho this might be right forNeutropeniaBreast Cancer EVIVE Biotechnology 18
Large-scale testing (Phase 3)Active Not RecruitingNCT03937154What this trial is testingStudy of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerWho this might be right forChemotherapy-induced Thrombocytopenia Amgen 145
Large-scale testing (Phase 3)Study completedNCT02872103What this trial is testingPlacebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic ChemotherapyWho this might be right forBreast CancerNeutropenia EVIVE Biotechnology 122
Not applicableStudy completedNCT05939193What this trial is testingEffect of Urine-guided Hydration on Acute Kidney Injury After CRS-HIPECWho this might be right forCytoreductive SurgeryHyperthermic Intraperitoneal ChemotherapyHydration+3 more Peking University First Hospital 168
Not applicableLooking for participantsNCT07670221What this trial is testingNurse-Led Self-Management Program on Taste Alteration in Women With Breast CancerWho this might be right forChemotherapy-Related Taste Alteration Izmir Bakircay University 68